These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8539797)
21. New antirejection drugs anticipated. Randall T JAMA; 1990 Sep; 264(10):1225. PubMed ID: 1696999 [No Abstract] [Full Text] [Related]
22. Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Hausen B; Morris RE Clin Chest Med; 1997 Jun; 18(2):353-66. PubMed ID: 9187827 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905 [No Abstract] [Full Text] [Related]
25. [Immunosuppressive agents--advances of the developmental studies and the mode of action]. Ochiai T; Isono K; Gunji Y; Nagata M Nihon Rinsho; 1991 Jun; 49(6):1436-41. PubMed ID: 1715926 [No Abstract] [Full Text] [Related]
26. Mycophenolate mofetil--a new immunosuppressant for organ transplantation. Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993 [No Abstract] [Full Text] [Related]
27. Maintenance immunosuppression after liver transplantation. Lake JR; Roberts JP; Ascher NL Semin Liver Dis; 1992 Feb; 12(1):73-9. PubMed ID: 1373916 [No Abstract] [Full Text] [Related]
28. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923 [No Abstract] [Full Text] [Related]
29. Renal transplantation for the nephrologist: new immunosuppressive drugs. First MR Am J Kidney Dis; 1992 Jan; 19(1):3-9. PubMed ID: 1371201 [No Abstract] [Full Text] [Related]
30. How to use mTOR inhibitors? The search goes on. Budde K Am J Transplant; 2011 Aug; 11(8):1551-2. PubMed ID: 21668636 [No Abstract] [Full Text] [Related]
32. Quality assessment issues of new immunosuppressive drugs and experimental experience. Holt DW; Jones K; Lee T; Stadler P; Johnston A Ther Drug Monit; 1996 Aug; 18(4):362-7. PubMed ID: 8857551 [TBL] [Abstract][Full Text] [Related]
33. Immunosuppression in the 21st century. Van Buren C Transplant Proc; 1998 May; 30(3):694-5. PubMed ID: 9595061 [No Abstract] [Full Text] [Related]
34. The development of immunosuppression: the rapamycin milestone. Calne RY Transplant Proc; 2003 May; 35(3 Suppl):15S-17S. PubMed ID: 12742463 [No Abstract] [Full Text] [Related]
35. Exceptional circumstances and heart transplantation. Coverdale A N Z Med J; 2005 Feb; 118(1209):U1290. PubMed ID: 15711623 [No Abstract] [Full Text] [Related]
38. Response to 'Exceptional circumstances and heart transplantation' letter. Tomlinson P; Moodie P N Z Med J; 2005 May; 118(1215):U1484. PubMed ID: 15915198 [No Abstract] [Full Text] [Related]
39. Suppression of immunoglobulin resynthesis after plasmapheresis: efficacy of various immunosuppressive drugs--a study in rats. Kozlowski T; Tibell A; Morpurgo E; Sundberg B; Sundin U; Groth C Transplant Proc; 1995 Dec; 27(6):3545-6. PubMed ID: 8540094 [No Abstract] [Full Text] [Related]
40. Immunosuppression in renal transplantation: where are we now? McDonald K; Jardine AG Hosp Med; 2003 Nov; 64(11):636-7. PubMed ID: 14671870 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]